167 related articles for article (PubMed ID: 14613115)
1. Synthesis and evaluation of three novel scyphostatin analogues as neutral sphingomyelinase inhibitors.
Pitsinos EN; Wascholowski V; Karaliota S; Rigou C; Couladouros EA; Giannis A
Chembiochem; 2003 Nov; 4(11):1223-5. PubMed ID: 14613115
[No Abstract] [Full Text] [Related]
2. Concise asymmetric total synthesis of scyphostatin, a potent inhibitor of neutral sphingomyelinase.
Fujioka H; Sawama Y; Kotoku N; Ohnaka T; Okitsu T; Murata N; Kubo O; Li R; Kita Y
Chemistry; 2007; 13(36):10225-38. PubMed ID: 17907134
[TBL] [Abstract][Full Text] [Related]
3. Concise approach to the carbocyclic core of the naturally occurring sphingomyelinase inhibitor scyphostatin.
Mehta G; Modugu NR
J Org Chem; 2013 Apr; 78(7):3367-73. PubMed ID: 23442124
[TBL] [Abstract][Full Text] [Related]
4. Short and efficient route to the fully functionalized polar core of scyphostatin.
Pitsinos EN; Cruz A
Org Lett; 2005 May; 7(11):2245-8. PubMed ID: 15901180
[TBL] [Abstract][Full Text] [Related]
5. Influence of the scyphostatin side chain on the mode of inhibition of neutral sphingomyelinase.
Wascholowski V; Giannis A; Pitsinos EN
ChemMedChem; 2006 Jul; 1(7):718-21. PubMed ID: 16902925
[No Abstract] [Full Text] [Related]
6. Synthesis and antiapoptotic activity of a novel analogue of the neutral sphingomyelinase inhibitor scyphostatin.
Claus RA; Wüstholz A; Müller S; Bockmeyer CL; Riedel NH; Kinscherf R; Deigner HP
Chembiochem; 2005 Apr; 6(4):726-37. PubMed ID: 15751001
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biochemical investigation of scyphostatin analogues as inhibitors of neutral sphingomyelinase.
Arenz C; Gartner M; Wascholowski V; Giannis A
Bioorg Med Chem; 2001 Nov; 9(11):2901-4. PubMed ID: 11597471
[TBL] [Abstract][Full Text] [Related]
8. Studies toward the total synthesis of scyphostatin: first entry to the highly functionalized cyclohexenone segment.
Izuhara T; Katoh T
Org Lett; 2001 May; 3(11):1653-6. PubMed ID: 11405678
[TBL] [Abstract][Full Text] [Related]
9. Total synthesis of (+)-scyphostatin, a potent and specific inhibitor of neutral sphingomyelinase.
Inoue M; Yokota W; Murugesh MG; Izuhara T; Katoh T
Angew Chem Int Ed Engl; 2004 Aug; 43(32):4207-9. PubMed ID: 15307088
[No Abstract] [Full Text] [Related]
10. Stereoselective reactions of a (-)-quinic acid-derived enone: application to the synthesis of the core of scyphostatin.
Murray LM; O'Brien P; Taylor RJ
Org Lett; 2003 May; 5(11):1943-6. PubMed ID: 12762692
[TBL] [Abstract][Full Text] [Related]
11. A short and efficient route to novel scyphostatin analogues.
Runcie KA; Taylor RJ
Org Lett; 2001 Oct; 3(21):3237-9. PubMed ID: 11594803
[TBL] [Abstract][Full Text] [Related]
12. Scyphostatin, a neutral sphingomyelinase inhibitor from a discomycete, Trichopeziza mollissima: taxonomy of the producing organism, fermentation, isolation, and physico-chemical properties.
Nara F; Tanaka M; Hosoya T; Suzuki-Konagai K; Ogita T
J Antibiot (Tokyo); 1999 Jun; 52(6):525-30. PubMed ID: 10470675
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of cytostatin analogues.
Bialy L; Waldmann H
Chem Commun (Camb); 2003 Aug; (15):1872-3. PubMed ID: 12932009
[TBL] [Abstract][Full Text] [Related]
14. Dynamic kinetic resolution during a vinylogous Payne rearrangement: a concise synthesis of the polar pharmacophoric subunit of (+)-scyphostatin.
Hoye TR; Jeffrey CS; Nelson DP
Org Lett; 2010 Jan; 12(1):52-5. PubMed ID: 19968321
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of novel phosphate ester analogs as neutral sphingomyelinase inhibitors.
Imagawa H; Oda M; Takemoto T; Yamauchi R; Yoshikawa T; Yamamoto H; Nishizawa M; Takahashi H; Hashimoto M; Yabiku K; Nagahama M; Sakurai J
Bioorg Med Chem Lett; 2010 Jul; 20(13):3868-71. PubMed ID: 20627555
[TBL] [Abstract][Full Text] [Related]
16. Synthesis (and alternative proof of configuration) of the scyphostatin C(1')-C(20') trienoyl fragment.
Hoye TR; Tennakoon MA
Org Lett; 2000 May; 2(10):1481-3. PubMed ID: 10814478
[TBL] [Abstract][Full Text] [Related]
17. A furan Diels-Alder cycloaddition approach to scyphostatin analogues.
Fraser CJ; Howell GP; Harrity JP
Org Biomol Chem; 2012 Dec; 10(45):9058-66. PubMed ID: 23086598
[TBL] [Abstract][Full Text] [Related]
18. Sphingolactones: selective and irreversible inhibitors of neutral sphingomyelinase.
Wascholowski V; Giannis A
Angew Chem Int Ed Engl; 2006 Jan; 45(5):827-30. PubMed ID: 16365835
[No Abstract] [Full Text] [Related]
19. Biological activities of scyphostatin, a neutral sphingomyelinase inhibitor from a discomycete, Trichopeziza mollissima.
Nara F; Tanaka M; Masuda-Inoue S; Yamasato Y; Doi-Yoshioka H; Suzuki-Konagai K; Kumakura S; Ogita T
J Antibiot (Tokyo); 1999 Jun; 52(6):531-5. PubMed ID: 10470676
[TBL] [Abstract][Full Text] [Related]
20. Total synthesis of alpha-pyrone meroterpenoids, novel bioactive microbial metabolites.
Sunazuka T; Omura S
Chem Rev; 2005 Dec; 105(12):4559-80. PubMed ID: 16351054
[No Abstract] [Full Text] [Related]
[Next] [New Search]
